Fluorouracil and Dose-Dense Chemotherapy in Adjuvant Treatment of Patient with Early-Stage Breast Cancer: an Open-Label, 2 x 2 Factorial, Randomised Phase III Trial

被引:0
|
作者
Colle, E. [1 ]
Besse, B. [2 ]
机构
[1] AERIO, Paris, France
[2] Gustave Roussy, F-94800 Villejuif, France
关键词
METAANALYSIS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:330 / 332
页数:3
相关论文
共 50 条
  • [1] Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 x 2 factorial, randomised phase 3 trial
    Del Mastro, Lucia y
    De Placido, Sabino
    Bruzzi, Paolo
    De Laurentiis, Michele
    Boni, Corrado
    Cavazzini, Giovanna
    Durando, Antonio
    Turletti, Anna
    Nistico, Cecilia
    Valle, Enrichetta
    Garrone, Ornella
    Puglisi, Fabio
    Montemurro, Filippo
    Barni, Sandro
    Ardizzoni, Andrea
    Gamucci, Teresa
    Colantuoni, Giuseppe
    Giuliano, Mario
    Gravina, Adriano
    Papaldo, Paola
    Bighin, Claudia
    Bisagni, Giancarlo
    Forestieri, Valeria
    Cognetti, Francesco
    LANCET, 2015, 385 (9980): : 1863 - 1872
  • [2] Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
    Del Mastro, Lucia
    Poggio, Francesca
    Blondeaux, Eva
    De Placido, Sabino
    Giuliano, Mario
    Forestieri, Valeria
    De laurentiis, Michelino
    Gravina, Adriano
    Bisagni, Giancarlo
    Rimanti, Anita
    Turletti, Anna
    Nistico, Cecilia
    Vaccaro, Angela
    Cognetti, Francesco
    Fabi, Alessandra
    Gasparro, Simona
    Garrone, Ornella
    Alicicco, Maria Grazia
    Urracci, Ylenia
    Mansutti, Mauro
    Poletti, Paola
    Correale, Pierpaolo
    Bighin, Claudia
    Puglisi, Fabio
    Montemurro, Filippo
    Colantuoni, Giuseppe
    Lambertini, Matteo
    Boni, Luca
    LANCET ONCOLOGY, 2022, 23 (12): : 1571 - 1582
  • [3] Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer
    Mayer, Erica L.
    Burstein, Harold J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1198 - 1200
  • [4] Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)
    Moebus, Volker
    Lueck, Hans-Joachim
    Ladda, Ekkehart
    Klare, Peter
    Schmidt, Marcus
    Schneeweiss, Andreas
    Grischke, Eva-Maria
    Wachsmann, Grischa
    Forstbauer, Helmut
    Untch, Michael
    Marme, Frederik
    Blohmer, Jens-Uwe
    Jackisch, Christian
    Huober, Jens
    Stickeler, Elmar
    Reinisch, Mattea
    Link, Theresa
    Sinn, Bruno, V
    Janni, Wolfgang
    Denkert, Carsten
    Furlanetto, Jenny
    Engels, Knut
    Solbach, Christine
    Schmatloch, Sabine
    Rey, Julia
    Burchardi, Nicole
    Loibl, Sibylle
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : 138 - 148
  • [5] Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
    Ellis, Paul
    Barrett-Lee, Peter
    Johnson, Lindsay
    Cameron, David
    Wardley, Andrew
    O'Reilly, Susan
    Verrill, Mark
    Smith, Ian
    Yarnold, John
    Coleman, Robert
    Earl, Helena
    Canney, Peter
    Twelves, Chris
    Poole, Christopher
    Bloomfield, David
    Hopwood, Penelope
    Johnston, Stephen
    Dowsett, Mitchell
    Bartlett, John M. S.
    Ellis, Ian
    Peckitt, Clare
    Hall, Emma
    Bliss, Judith M.
    LANCET, 2009, 373 (9676): : 1681 - 1692
  • [6] Dose-dense adjuvant chemotherapy in early-stage breast cancer patients: End-of-study results from a randomised, phase III trial of the Gruppo Italiano Mammella GIM)
    Del Mastro, L.
    Poggio, F.
    Blondeaux, E.
    de Placido, S.
    Giuliano, M.
    De laurentiis, M.
    Bisagni, G.
    Cantore, M.
    Turletti, A.
    Nistico, C.
    Urracci, Y.
    Garrone, O.
    Bighin, C.
    Mansutti, M.
    Montemurro, F.
    Colantuoni, G.
    Lambertini, M.
    Boni, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S599 - S600
  • [7] Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial
    Del Mastro, Lucia
    Mansutti, Mauro
    Bisagni, Giancarlo
    Ponzone, Riccardo
    Durando, Antonio
    Amaducci, Laura
    Campadelli, Enrico
    Cognetti, Francesco
    Frassoldati, Antonio
    Michelotti, Andrea
    Mura, Silvia
    Urracci, Ylenia
    Sanna, Giovanni
    Gori, Stefania
    De Placido, Sabino
    Garrone, Ornella
    Fabi, Alessandra
    Barone, Carla
    Tamberi, Stefano
    Bighin, Claudia
    Puglisi, Fabio
    Moretti, Gabriella
    Arpino, Grazia
    Ballestrero, Alberto
    Poggio, Francesca
    Lambertini, Matteo
    Montemurro, Filippo
    Bruzzi, Paolo
    LANCET ONCOLOGY, 2021, 22 (10): : 1458 - 1467
  • [8] Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial
    van de Voort, Elles M. F.
    Struik, Gerson M.
    Koppert, Linetta B.
    Moelker, Adriaan
    Debets, Reno
    Yo, Glenn
    Macco, Maura J. P., V
    Sinke, Renata H. J. A.
    Franckena, Martine
    Birnie, Erwin
    Verhoef, Cornelis
    Klem, Taco M. A. L.
    BMJ OPEN, 2021, 11 (09):
  • [9] Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
    Ribrag, Vincent
    Koscielny, Serge
    Bosq, Jacques
    Leguay, Thibaut
    Casasnovas, Olivier
    Fornecker, Luc-Mathieu
    Recher, Christian
    Ghesquieres, Herve
    Morschhauser, Franck
    Girault, Stephane
    Le Gouill, Steven
    Ojeda-Uribe, Mario
    Mariette, Clara
    Cornillon, Jerome
    Cartron, Guillaume
    Verge, Veronique
    Chassagne-Clement, Catherine
    Dombret, Herve
    Coiffier, Bertrand
    Lamy, Thierry
    Tilly, Herve
    Salles, Gilles
    LANCET, 2016, 387 (10036): : 2402 - 2411
  • [10] Dose-dense therapy in the treatment of early-stage breast cancer: An overview of the data
    McArthur, Heather L.
    Hudis, Clifford A.
    CLINICAL BREAST CANCER, 2007, 8 : S6 - S10